S&P 500 falls slightly Friday, but rides 9-week win streak to end 2023 with 24% gain: Live updates
Stocks fell slightly on Friday, but the S&P 500 closed out 2023 with a surprising gain of 24%.
Fake reviews are a multibillion-dollar quicksand — here’s how to avoid getting sucked in
For many, a string of glowing reviews, or the mark of five golden stars, usually seals the deal in a purchase decision. But what’s real and what’s phony?
CNBC Daily Open: For the S&P, the last mile’s the longest
The S&P 500’s tantalizingly close to an all-time high. The index added 0.04% yesterday to close at 4,783.35, just about 10 points away from its record close.
Fund managers turn cautious on European stocks, BofA survey shows — here’s why
Fund managers strike a cautious tone on the prospects of the European economy — and stock market — going into 2024, but see some opportunities.
Piper Sandler reveals its top 3 biotech stock picks for 2024 — and gives one 90% upside
“After another difficult year, there are signs that biotech is recovering into 2024,” the investment bank says, citing the prospect of interest rate cuts.
Could a bitcoin ETF approval be a sell-the-news event? Here’s what to expect if it happens
A bitcoin ETF approval is expected in the coming weeks, but the market may be a little overheated. Here’s what to expect of it happens.
Cathie Wood’s ARK invests in ProShares Bitcoin Strategy ETF after exiting GBTC: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry….
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might have in store.
